Joel Bergman
7Patents
3h-index
9Co-inventors
42Inventor score
Filing activity: Jan 31, 2012 → Sep 5, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9249087B2 | HDAC inhibitors and therapeutic methods using the same | Emerging Cross-Sectional Technologies | 44 | Active |
| US9751832B2 | Selective histone deactylase 6 inhibitors | Chemistry; Metallurgy | 7 | Active |
| US9409858B2 | Selective histone deactylase 6 inhibitors | Human Necessities | 6 | Active |
| USRE47009E1 | HDAC inhibitors and therapeutic methods using the same | General | 2 | Active |
| US10456394B2 | Tetrahydroquinoline substituted hydroxamic acids as selective histone deacetylase 6 inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US9956192B2 | Selective histone deactylase 6 inhibitors | Human Necessities | 0 | Active |
| US10227295B2 | Selective histone deactylase 6 inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.